These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21737953)

  • 1. A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats.
    Sunagawa Y; Morimoto T; Wada H; Takaya T; Katanasaka Y; Kawamura T; Yanagi S; Marui A; Sakata R; Shimatsu A; Kimura T; Kakeya H; Fujita M; Hasegawa K
    Circ J; 2011; 75(9):2151-9. PubMed ID: 21737953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal dose-setting study of curcumin for improvement of left ventricular systolic function after myocardial infarction in rats.
    Sunagawa Y; Sono S; Katanasaka Y; Funamoto M; Hirano S; Miyazaki Y; Hojo Y; Suzuki H; Morimoto E; Marui A; Sakata R; Ueno M; Kakeya H; Wada H; Hasegawa K; Morimoto T
    J Pharmacol Sci; 2014; 126(4):329-36. PubMed ID: 25409899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction.
    Inthachai T; Lekawanvijit S; Kumfu S; Apaijai N; Pongkan W; Chattipakorn SC; Chattipakorn N
    Exp Physiol; 2015 Jun; 100(6):667-79. PubMed ID: 25823534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the angiotensin-converting enzyme inhibitor enalapril on sympathetic neuronal function and beta-adrenergic desensitization in heart failure after myocardial infarction in rats.
    Igawa A; Nozawa T; Yoshida N; Fujii N; Kato B; Inoue M; Tazawa S; Yamada Y; Asanoi H; Inoue H
    Jpn Heart J; 2002 Nov; 43(6):675-88. PubMed ID: 12558131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of continuous infusion of brain natriuretic peptides on postmyocardial infarction ventricular remodelling in rats.
    Pan Y; Zhu W; Ma J; Xin P; Han B; He Y; Wang Y; Peng T; Wei M
    Arch Cardiovasc Dis; 2011 Jan; 104(1):17-28. PubMed ID: 21276574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The impact of nitrates and mono-therapy and nitrates combined with angiotensin converting enzyme inhibitors on left ventricular remodeling and exercise capacity in patients after acute myocardial infarction].
    Maciejewicz J; Maziarz A; Celibała R; Wiśniewski M; Wiśniewska M
    Przegl Lek; 2003; 60(2):80-4. PubMed ID: 12939852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nisoldipine and/or enalapril on left ventricular function and exercise capacity in patients with recent anterior myocardial infarction and mild cardiac dysfunction.
    Romano M; Cardei S; de Arcangelis E; Monteforte I; Capaldo M; Muto P; Marchegiano R; Kilama MO; Condorelli M
    Am Heart J; 1997 Mar; 133(3):268-72. PubMed ID: 9060793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.
    Guo X; Wang J; Elimban V; Dhalla NS
    Can J Physiol Pharmacol; 2008 Apr; 86(4):139-47. PubMed ID: 18418421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late coronary artery reperfusion has additive beneficial effects on infarct expansion when combined with early angiotensin converting enzyme inhibitor therapy post myocardial infarction.
    Duchatellier T; Brown EJ; Alhaddad IA
    Cardiovasc Drugs Ther; 2001 Jan; 15(1):49-54. PubMed ID: 11504163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure.
    Funabiki K; Onishi K; Dohi K; Koji T; Imanaka-Yoshida K; Ito M; Wada H; Isaka N; Nobori T; Nakano T
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2487-92. PubMed ID: 15548724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse.
    Patten RD; Aronovitz MJ; Einstein M; Lambert M; Pandian NG; Mendelsohn ME; Konstam MA
    Clin Sci (Lond); 2003 Feb; 104(2):109-18. PubMed ID: 12546633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of enalapril initiated early after acute myocardial infarction on heart failure parameters, with reference to clinical class and echocardiographic determinants. CONSENSUS II Multi-Echo Study Group.
    Edner M; Bonarjee VV; Nilsen DW; Berning J; Carstensen S; Caidahl K
    Clin Cardiol; 1996 Jul; 19(7):543-8. PubMed ID: 8818434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three doses of enalapril in preventing left ventricular remodeling after acute myocardial infarction in the rat.
    Yang Y; Zhang P; Song L; Ruan Y; Xu X; Li Y; Zhou Y; Tian Y; Xu Y; Chen Z
    Chin Med J (Engl); 2002 Mar; 115(3):347-51. PubMed ID: 11940361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
    Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
    Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
    Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of enalapril on left ventricular remodelling in patients with a severe residual stenosis after acute anterior wall infarction.
    Baur LH; Schipperheyn JJ; van der Wall EE; van der Velde EA; Schalij MJ; van Eck-Smit BL; van der Laarse A; Voogd PJ; Sedney MI; Reiber JH; Bruschke AV
    Eur Heart J; 1997 Aug; 18(8):1313-21. PubMed ID: 9458425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model.
    Jugdutt BI
    J Am Coll Cardiol; 1995 Jun; 25(7):1718-25. PubMed ID: 7759729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan.
    Wang J; Guo X; Dhalla NS
    Biochim Biophys Acta; 2004 Oct; 1690(2):177-84. PubMed ID: 15469907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats.
    Taylor K; Patten RD; Smith JJ; Aronovitz MJ; Wight J; Salomon RN; Konstam MA
    J Cardiovasc Pharmacol; 1998 May; 31(5):654-60. PubMed ID: 9593063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of converting enzyme inhibition on left ventricular volumes and ejection fraction in patients receiving beta-blockade after myocardial infarction. CONSENSUS II multiecho study group.
    Bonarjee VV; Carstensen S; Caidahl K; Nilsen DW; Edner M; Lindvall K; Snapinn SM; Berning J
    Am Heart J; 1996 Jul; 132(1 Pt 1):71-7. PubMed ID: 8701878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.